The Japan Research Institute is impressed by BioIPSeeds

Today, Japan Research Institute(JPI) visited TRPMA to promote Japanese IP to global Pharmaceutical firms in 2017. TRPMA suggested BioIPSeeds as a best tool for individual researchers to reach global Pharmaceutical firms. BioIPSeeds uses the most frontier blockchain technology to project researchers’ ideas and use online NDA to accelerate the academia-industry cooperation. After a short demo, JRI is fully surprised by BioIPSeeds and invites TRPMA’s COO Carol Cheng to introduce BioIPSeeds in Japan on March.